• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Apollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana Health

    1/24/24 8:00:00 AM ET
    $AMEH
    Professional Services
    Consumer Discretionary
    Get the next $AMEH alert in real time by email

    ALHAMBRA, Calif., Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value care to all, today announced it plans to change its name to Astrana Health, effective February 26, 2024. Alongside the planned corporate name change, the Company's common stock is intended to begin trading under the new symbol "ASTH" on the NASDAQ, effective February 26, 2024.

    ameh logo (PRNewsfoto/Apollo Medical Holdings, Inc.)

    Astrana Health was founded in 1992 by physicians to empower physicians in delivering best-in-class healthcare for their local communities. Today, it serves around 900,000 members in value-based care arrangements, with a multi-payer approach and diversified business across Medicare, Medicaid, Commercial, and the ACA Marketplace. Astrana Health currently partners with over 10,000 affiliated providers and operates 61 outpatient locations nationwide, all supported by its purpose-built, proprietary technology platform.

    Brandon Sim, President and CEO of Astrana Health, stated, "Astrana Health represents a unifying brand that reflects our rapidly expanding national footprint and our deep commitment to providing high-quality care to local communities across the country. Our new name is inspired by roots that refer to 'a collection of stars', paying homage to our Company's founding physicians and aptly representing the Company's star providers and teammates, who are allying together to deliver accessible, high-quality, and high-value care as a well-coordinated network, or constellation, to patients nationwide. We are excited to unite under our new brand and further accelerate our mission to deliver exceptional patient experiences and to provide quality care to all. We are more energized than ever to lead the transformation towards value-based healthcare."

    Patients and partners can expect the same industry-leading level of care, expertise, and commitment from Astrana Health. The organization remains dedicated to upholding the highest standards of healthcare delivery, while delivering value for patients, providers, payers, and partners.

    Branding across the Company will be rolled out in phases and will transition over the coming months.

    About Apollo Medical Holdings, Inc.

     ApolloMed is a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, ApolloMed operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

    Headquartered in Alhambra, California, ApolloMed's subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), and entities participating in the Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation models. For more information, please visit www.apollomed.net.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company's prospects Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company's reports to the Securities and Exchange Commission, including, without limitation, the risk factors discussed in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2022, and any subsequent quarterly reports on Form 10-Q. Any forward-looking statement made by the Company in this release speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.

    FOR MORE INFORMATION, PLEASE CONTACT:

    Investor Relations

    Asher Dewhurst

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-announces-planned-corporate-rebrand-as-astrana-health-302042878.html

    SOURCE Apollo Medical Holdings, Inc.

    Get the next $AMEH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMEH

    DatePrice TargetRatingAnalyst
    2/22/2024$44.00 → $55.00Neutral → Buy
    BofA Securities
    1/24/2024$45.00Buy
    Stifel
    12/22/2023$41.00Hold
    Truist
    10/17/2023$45.00Buy
    BTIG Research
    4/12/2023$44.00Neutral
    BofA Securities
    12/19/2022$40.00Buy
    Lake Street
    9/21/2022Outperform
    William Blair
    1/11/2022$93.00Buy
    Colliers Securities
    More analyst ratings

    $AMEH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      2/13/24 4:58:57 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13D/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      11/17/23 4:15:14 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      2/9/23 11:07:39 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.

      ALHAMBRA, Calif., Feb. 22, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, announced today it will formally change its name from Apollo Medical Holdings, Inc. ("ApolloMed") to Astrana Health, Inc. ("Astrana Health"). As previously announced, the Company will begin trading under the ticker symbol "ASTH." Both changes will take effect February 26, 2024.

      2/22/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

      ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      1/31/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

      ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra

      1/29/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Apollo Medical upgraded by BofA Securities with a new price target

      BofA Securities upgraded Apollo Medical from Neutral to Buy and set a new price target of $55.00 from $44.00 previously

      2/22/24 9:10:05 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Stifel initiated coverage on Apollo Medical with a new price target

      Stifel initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00

      1/24/24 6:57:05 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Truist initiated coverage on Apollo Medical with a new price target

      Truist initiated coverage of Apollo Medical with a rating of Hold and set a new price target of $41.00

      12/22/23 7:19:49 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kumar Dinesh M. was granted 150,395 shares (SEC Form 4)

      4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      1/24/24 4:31:15 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Kumar Dinesh M.

      3 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      1/24/24 4:30:18 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Vong John was granted 14,352 shares, increasing direct ownership by 293% to 19,253 units (SEC Form 4)

      4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      12/19/23 9:10:18 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Financials

    Live finance-specific insights

    See more
    • Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

      ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      1/31/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results

      Company to Host Conference Call on Monday, August 7, 2023, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Aug. 7, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the second quarter ended June 30, 2023. Brandon Sim, Co-Chief Executive Officer of ApolloMed, stated, "Our strong

      8/7/23 5:17:00 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Schedules 2023 Second Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., July 28, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the second quarter ended June 30, 2023, after the close of the stock market on Monday, August 7, 2023. The Company will discuss those results in a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      7/28/23 8:05:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    SEC Filings

    See more
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/29/24 6:03:30 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/27/24 4:19:15 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/26/24 6:04:01 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Leadership Updates

    Live Leadership Updates

    See more
    • ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

      ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra

      1/29/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Akido Appoints Eric Chin as its first Chief Financial Officer As the Company Prepares to Accelerate Growth

      LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Akido, a tech-integrated medical network reimagining healthcare from the ground up, announced that Eric Chin has been appointed Chief Financial Officer, effective immediately. Chin will work closely with Akido's co-founders as the company continues to bring its unique blend of AI-powered technology, best-in-class medical services and scalable preventive care programs to new markets across the U.S. Previously, Chin served as Chief Financial Officer at Apollo Medical Holdings (ApolloMed), a publicly traded physician-centric technology-powered healthcare company (NASDAQ:AMEH) that increased reported total revenue from approximately $520 million i

      1/31/23 9:30:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • The Oncology Institute Names Mihir Shah as Chief Financial Officer

      CERRITOS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ:TOI) today announced the appointment of Mihir Shah as chief financial officer, effective immediately. In this role, Mr. Shah will lead the Accounting, Finance, Revenue Cycle Management, and Investor Relations functions, playing a key role in driving TOI's public company success and executing the strategic growth plan. Mr. Shah succeeds Scott Dalgleish, who will serve as a senior advisor through a transition period. Mr. Shah joins TOI with fifteen years of industry leadership experience across public, private, and not-for-profit organizations. Most recently Mr. Shah served as chief fi

      4/4/22 6:01:00 AM ET
      $AMEH
      $TOI
      Professional Services
      Consumer Discretionary
      Medical/Nursing Services
      Health Care